메뉴 건너뛰기




Volumn 66, Issue 1, 2014, Pages 179-180

Is it possible that one patient may again experience a response to abiraterone acetate withdrawal during an abiraterone acetate rechallenge?

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE ACETATE; DOCETAXEL; PROSTATE SPECIFIC ANTIGEN; 17-(3-PYRIDYL)-5,16-ANDROSTADIEN-3BETA-ACETATE; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT;

EID: 84902082468     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.03.014     Document Type: Letter
Times cited : (4)

References (5)
  • 1
    • 84888014912 scopus 로고    scopus 로고
    • Metabolic and prostate-specific antigen response after abiraterone acetate withdrawal: A new clinical scenario for castration-resistant prostate cancer?
    • O. Caffo, A. Palermo, and A. Veccia et al. Metabolic and prostate-specific antigen response after abiraterone acetate withdrawal: a new clinical scenario for castration-resistant prostate cancer? Clin Genitourin Cancer 11 2013 e10 e14
    • (2013) Clin Genitourin Cancer , vol.11
    • Caffo, O.1    Palermo, A.2    Veccia, A.3
  • 2
    • 84886953295 scopus 로고    scopus 로고
    • Is there a withdrawal syndrome with abiraterone acetate (AA) [abstract 89]?
    • L. Albiges, E. Auclin, and B. Rousseau et al. Is there a withdrawal syndrome with abiraterone acetate (AA) [abstract 89]? J Clin Oncol 31 Suppl 6 2013
    • (2013) J Clin Oncol , vol.31 , Issue.SUPPL. 6
    • Albiges, L.1    Auclin, E.2    Rousseau, B.3
  • 3
    • 84886949687 scopus 로고    scopus 로고
    • Biochemical and objective response to abiraterone acetate withdrawal: Incidence and clinical relevance of a new scenario for castration-resistant prostate cancer
    • O. Caffo, A. Palermo, and A. Veccia et al. Biochemical and objective response to abiraterone acetate withdrawal: incidence and clinical relevance of a new scenario for castration-resistant prostate cancer Urology 82 2013 1090 1093
    • (2013) Urology , vol.82 , pp. 1090-1093
    • Caffo, O.1    Palermo, A.2    Veccia, A.3
  • 4
    • 84891829537 scopus 로고    scopus 로고
    • Evaluation of prostate-specific antigen response following cessation of abiraterone acetate: Is there evidence for a withdrawal syndrome?
    • A.A. Azad, and B.J. Eigl Evaluation of prostate-specific antigen response following cessation of abiraterone acetate: is there evidence for a withdrawal syndrome? Eur Urol 65 2014 504 505
    • (2014) Eur Urol , vol.65 , pp. 504-505
    • Azad, A.A.1    Eigl, B.J.2
  • 5
    • 84947219460 scopus 로고    scopus 로고
    • In vitro reproduction and explanation of an abiraterone acetate withdrawal phenomenon [abstract 154]
    • P. Thelen, H. Jarry, and L. Trojan et al. In vitro reproduction and explanation of an abiraterone acetate withdrawal phenomenon [abstract 154] J Clin Oncol 32 Suppl 4 2014
    • (2014) J Clin Oncol , vol.32 , Issue.SUPPL. 4
    • Thelen, P.1    Jarry, H.2    Trojan, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.